WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for FATE

Based on 8 analysts offering 12 month price targets for Fate Therapeutics Inc.
Min Forecast
$4.00+12.99%
Avg Forecast
$6.50+83.62%
Max Forecast
$10.00+182.49%

Should I buy or sell FATE stock?

Based on 8 analysts offering ratings for Fate Therapeutics Inc.
Hold
Strong Buy
2 analysts 25%
Buy
0 analysts 0%
Hold
5 analysts 62.5%
Sell
1 analysts 12.5%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FATE stock forecasts and price targets.

FATE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-10
Bank of America
Bottom 12%
12
SellMaintains$6.00+69.49%2024-03-28
Morgan Stanley
Top 7%
94
HoldMaintains$7.00+97.74%2024-02-27
Barclays
Top 27%
74
Strong BuyMaintains$10.00+182.49%2024-02-27

1 of 1

Forecast return on equity

Is FATE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.79%

Forecast return on assets

Is FATE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FATE revenue forecast

What is FATE's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$4.3M-33%
Avg 2 year Forecast
$3.6M-44.43%
Avg 3 year Forecast
$29.5M+355.54%
FATE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FATE revenue growth forecast

How is FATE forecast to perform vs Biotechnology companies and vs the US market?
Company
303.85%
Industry
35.65%
Market
10.58%
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FATE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FATE$3.54$6.50+83.62%Hold
SLRN$4.05$13.00+220.99%Hold
TERN$6.32$14.38+127.45%Buy
TBPH$8.41$20.50+143.76%Strong Buy
NGNE$31.71$42.67+34.55%Strong Buy

Fate Therapeutics Stock Forecast FAQ

Is Fate Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: FATE) stock is to Hold FATE stock.

Out of 8 analysts, 2 (25%) are recommending FATE as a Strong Buy, 0 (0%) are recommending FATE as a Buy, 5 (62.5%) are recommending FATE as a Hold, 1 (12.5%) are recommending FATE as a Sell, and 0 (0%) are recommending FATE as a Strong Sell.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.

What is FATE's revenue growth forecast for 2024-2027?

(NASDAQ: FATE) Fate Therapeutics's forecast annual revenue growth rate of 303.85% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.58%.

Fate Therapeutics's revenue in 2024 is $6,478,000.On average, 7 Wall Street analysts forecast FATE's revenue for 2024 to be $494,030,745, with the lowest FATE revenue forecast at $219,126,540, and the highest FATE revenue forecast at $1,013,104,524. On average, 2 Wall Street analysts forecast FATE's revenue for 2025 to be $409,795,088, with the lowest FATE revenue forecast at $364,262,301, and the highest FATE revenue forecast at $455,327,876.

In 2027, FATE is forecast to generate $3,359,181,405 in revenue, with the lowest revenue forecast at $3,359,181,405 and the highest revenue forecast at $3,359,181,405.

What is FATE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FATE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is FATE's Price Target?

According to 8 Wall Street analysts that have issued a 1 year FATE price target, the average FATE price target is $6.50, with the highest FATE stock price forecast at $10.00 and the lowest FATE stock price forecast at $4.00.

On average, Wall Street analysts predict that Fate Therapeutics's share price could reach $6.50 by May 16, 2025. The average Fate Therapeutics stock price prediction forecasts a potential upside of 83.62% from the current FATE share price of $3.54.

What is FATE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FATE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.